Phosphatidylserine targeting for diagnosis and treatment of human diseases

Apoptosis

Volumn 15, Issue 9, 2010, Pages 1072-1082

  Schutters, Kristof ^a   Reutelingsperger, Chris ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Annexin A5; Apoptosis; Molecular Imaging; Phosphatidylserine; Targeted Drug Delivery

Indexed keywords

ANTINEOPLASTIC AGENT; BAVITUXIMAB; BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; DIANNEXIN; HOMODIMER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LACTADHERIN; LIPOCORTIN 5; MUCIN 1; MUCIN 4; PHOSPHATIDYLSERINE; SYNAPTOTAGMIN I; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CELL DEATH; CELL MEMBRANE; CELL SURFACE; COLORECTAL ADENOCARCINOMA; COLORECTAL CARCINOMA; DRUG DELIVERY SYSTEM; DRUG TARGETING; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR IMAGING; NEAR INFRARED SPECTROSCOPY; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; ANNEXIN A5; DIAGNOSIS; DIAGNOSTIC IMAGING; DRUG THERAPY; HUMANS; PHOSPHATIDYLSERINES; PROTEIN BINDING; SYNAPTOTAGMIN I;

ANIMALIA;

EID: 77956914523     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-010-0503-y     Document Type: Review

References (142)

1. JE Vance R Steenbergen 2005 Metabolism and functions of phosphatidylserine Prog Lipid Res 44 4 207 234 1:CAS:528:DC%2BD2MXmt1Srsbo%3D 15979148
2. CL Stace NT Ktistakis 2006 Phosphatidic acid- and phosphatidylserine- binding proteins Biochim Biophys Acta 1761 8 913 926 1:CAS:528: DC%2BD28XpsVajsbk%3D 16624617
3. T Yeung, et al. 2008 Membrane phosphatidylserine regulates surface charge and protein localization Science 319 5860 210 213 1:CAS:528: DC%2BD1cXis1alsg%3D%3D 18187657
4. A Yamaji-Hasegawa M Tsujimoto 2006 Asymmetric distribution of phospholipids in biomembranes Biol Pharm Bull 29 8 1547 1553 1:CAS:528:DC%2BD28XhtVWgsrzP 16880602
5. MO Bergo, et al. 2002 Defining the importance of phosphatidylserine synthase 2 in mice J Biol Chem 277 49 47701 47708 1:CAS:528:DC%2BD38XptFSqt70%3D 12361952
6. D Arikketh R Nelson JE Vance 2008 Defining the importance of phosphatidylserine synthase-1 (PSS1): unexpected viability of PSS1-deficient mice J Biol Chem 283 19 12888 12897 1:CAS:528:DC%2BD1cXltlGrsb4%3D 18343815
7. JC Holthuis TP Levine 2005 Lipid traffic: floppy drives and a superhighway Nat Rev Mol Cell Biol 6 3 209 220 1:CAS:528:DC%2BD2MXhslSlsLg%3D 15738987
8. G Morrot, et al. 1989 Aminophospholipid translocase of human erythrocytes: phospholipid substrate specificity and effect of cholesterol Biochemistry 28 8 3456 3462 1:CAS:528:DyaL1MXhslSkur0%3D 2742848
9. CF Puts JC Holthuis 2009 Mechanism and significance of P4 ATPase-catalyzed lipid transport: lessons from a Na+/K+-pump Biochim Biophys Acta 1791 7 603 611 1:CAS:528:DC%2BD1MXnt1GnsLw%3D 19233312
10. PF Devaux 1992 Protein involvement in transmembrane lipid asymmetry Annu Rev Biophys Biomol Struct 21 417 439 1:CAS:528:DyaK38Xlt1Kms7s%3D 1525472
11. M Bitbol, et al. 1987 Ion regulation of phosphatidylserine and phosphatidylethanolamine outside-inside translocation in human erythrocytes Biochim Biophys Acta 904 2 268 282 1:CAS:528:DyaL2sXmtlers70%3D 3117114
12. RF Zwaal AJ Schroit 1997 Pathophysiologic implications of membrane phospholipid asymmetry in blood cells Blood 89 4 1121 1132 1:CAS:528: DyaK2sXhtFWrsrg%3D 9028933
13. VA Fadok, et al. 1992 Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages J Immunol 148 7 2207 2216 1:CAS:528:DyaK38XisFers7g%3D 1545126
14. 2+-dependent transbilayer movement of phospholipid J Biol Chem 271 29 17205 17210 1:CAS:528:DyaK28XksFamtrs%3D 8663431
15. P Williamson, et al. 1995 Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets Biochemistry 34 33 10448 10455 1:CAS:528:DyaK2MXnt1Kltr4%3D 7654698
16. B Verhoven RA Schlegel P Williamson 1995 Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes J Exp Med 182 5 1597 1601 1:CAS:528:DyaK2MXovFWqsLk%3D 7595231
17. Q Zhou, et al. 1997 Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids J Biol Chem 272 29 18240 18244 1:CAS:528: DyaK2sXkslKqtLc%3D 9218461
18. Q Zhou, et al. 2002 Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1 Blood 99 11 4030 4038 1:CAS:528:DC%2BD38XktFyrsL0%3D 12010804
19. Q Zhou, et al. 2000 Transcriptional control of the human plasma membrane phospholipid scramblase 1 gene is mediated by interferon-alpha Blood 95 8 2593 2599 1:CAS:528:DC%2BD3cXisVaitrg%3D 10753839
20. P Williamson, et al. 2001 Phospholipid scramblase activation pathways in lymphocytes Biochemistry 40 27 8065 8072 1:CAS:528:DC%2BD3MXkt1Wktrw%3D 11434775
21. B Mirnikjoo K Balasubramanian AJ Schroit 2009 Suicidal membrane repair regulates phosphatidylserine externalization during apoptosis J Biol Chem 284 34 22512 22516 1:CAS:528:DC%2BD1MXpvFKisbo%3D 19561081
22. TM Allen P Williamson RA Schlegel 1988 Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface Proc Natl Acad Sci USA 85 21 8067 8071 1:CAS:528: DyaL1cXmtlKrtbY%3D 3186707
23. JW Heemskerk EM Bevers T Lindhout 2002 Platelet activation and blood coagulation Thromb Haemost 88 2 186 193 1:CAS:528:DC%2BD38XmsVSmsr0%3D 12195687
24. Y Hamon, et al. 2000 ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine Nat Cell Biol 2 7 399 406 1:CAS:528:DC%2BD3cXkvFCqtro%3D 10878804
25. J Mercer A Helenius 2008 Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells Science 320 5875 531 535 1:CAS:528:DC%2BD1cXkvFGkt70%3D 18436786
26. MM Soares SW King PE Thorpe 2008 Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases Nat Med 14 12 1357 1362 1:CAS:528:DC%2BD1cXhsVWgsr3I 19029986
27. MO Hengartner 2000 The biochemistry of apoptosis Nature 407 6805 770 776 1:CAS:528:DC%2BD3cXnsFWrsLc%3D 11048727
28. SJ Martin, et al. 1996 Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity J Biol Chem 271 46 28753 28756 1:CAS:528:DyaK28XntFKntLY%3D 8910516
29. SM van den Eijnde, et al. 1998 Cell surface exposure of phosphatidylserine during apoptosis is phylogenetically conserved Apoptosis 3 1 9 16 14646513
30. KS Ravichandran U Lorenz 2007 Engulfment of apoptotic cells: signals for a good meal Nat Rev Immunol 7 12 964 974 1:CAS:528:DC%2BD2sXhtlCrsL%2FF 18037898
31. RA Chaurio, et al. 2009 Phospholipids: key players in apoptosis and immune regulation Molecules 14 12 4892 4914 1:CAS:528:DC%2BD1MXhsFeju7zM 20032867
32. M Leist M Jaattela 2001 Four deaths and a funeral: from caspases to alternative mechanisms Nat Rev Mol Cell Biol 2 8 589 598 1:CAS:528: DC%2BD3MXlvVOqs78%3D 11483992
33. C Burtea, et al. 2009 Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques Mol Pharm 6 6 1903 1919 1:CAS:528:DC%2BD1MXht1Wkur7P 19743879
34. K Igarashi, et al. 1995 A novel phosphatidylserine-binding peptide motif defined by an anti-idiotypic monoclonal antibody. Localization of phosphatidylserine-specific binding sites on protein kinase C and phosphatidylserine decarboxylase J Biol Chem 270 49 29075 29078 1:CAS:528:DyaK2MXpvVOhtbs%3D 7493929
35. C Laumonier, et al. 2006 A new peptidic vector for molecular imaging of apoptosis, identified by phage display technology J Biomol Screen 11 5 537 545 1:CAS:528:DC%2BD28XpslWjtbY%3D 16760366
36. N Thapa, et al. 2008 Discovery of a phosphatidylserine recognizing peptide and its utility in molecular imaging of tumor apoptosis J Cell Mol Med 12 5A 1649 1660 1:CAS:528:DC%2BD1cXhsVarsbfI 18363834
37. RG Hanshaw BD Smith 2005 New reagents for phosphatidylserine recognition and detection of apoptosis Bioorg Med Chem 13 17 5035 5042 1:CAS:528: DC%2BD2MXmvVKhtrY%3D 15914007
38. CP Reutelingsperger G Hornstra HC Hemker 1985 Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord Eur J Biochem 151 3 625 629 1:CAS:528:DyaL2MXltl2gtbc%3D 3896792
39. R Huber J Romisch EP Paques 1990 The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes EMBO J 9 12 3867 3874 1:CAS:528:DyaK3MXnslamsA%3D%3D 2147412
40. R Huber, et al. 1990 The calcium binding sites in human annexin V by crystal structure analysis at 2.0 A resolution. Implications for membrane binding and calcium channel activity FEBS Lett 275 1-2 15 21 1:CAS:528:DyaK3MXnslaltA%3D%3D 2148156
41. MA Swairjo, et al. 1995 Ca(2+)-bridging mechanism and phospholipid head group recognition in the membrane-binding protein annexin V Nat Struct Biol 2 11 968 974 1:CAS:528:DyaK2MXptlegtrw%3D 7583670
42. P Montaville, et al. 2002 A new consensus sequence for phosphatidylserine recognition by annexins J Biol Chem 277 27 24684 24693 1:CAS:528: DC%2BD38XltlOhtb4%3D 11948176
43. F Oling W Bergsma-Schutter A Brisson 2001 Trimers, dimers of trimers, and trimers of trimers are common building blocks of annexin a5 two-dimensional crystals J Struct Biol 133 1 55 63 1:CAS:528:DC%2BD3MXjsFWgsrw%3D 11356064
44. H Kenis, et al. 2004 Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry J Biol Chem 279 50 52623 52629 1:CAS:528:DC%2BD2cXhtVCkurrI 15381697
45. MS Perin, et al. 1991 Structural and functional conservation of synaptotagmin (p65) in Drosophila and humans J Biol Chem 266 1 615 622 1:CAS:528:DyaK3MXktVait70%3D 1840599
46. MS Perin, et al. 1990 Phospholipid binding by a synaptic vesicle protein homologous to the regulatory region of protein kinase C Nature 345 6272 260 263 1:CAS:528:DyaK3cXltFWju7g%3D 2333096
47. MS Perin, et al. 1991 Domain structure of synaptotagmin (p65) J Biol Chem 266 1 623 629 1:CAS:528:DyaK3MXlslOrsQ%3D%3D 1985919
48. 2+/phospholipid-binding fold Cell 80 6 929 938 1:CAS:528:DyaK2MXkslOmur8%3D 7697723
49. X Zhang J Rizo TC Sudhof 1998 Mechanism of phospholipid binding by the C2A-domain of synaptotagmin I Biochemistry 37 36 12395 12403 1:CAS:528:DyaK1cXltFKqtbg%3D 9730811
50. 2+-binding domain J Biol Chem 273 26 15879 15882 1:CAS:528:DyaK1cXkt1Gitr8%3D 9632630
51. D Murray B Honig 2002 Electrostatic control of the membrane targeting of C2 domains Mol Cell 9 1 145 154 1:CAS:528:DC%2BD38XhtVyjsLg%3D 11804593 (Pubitemid 34127778)
52. W Kuo, et al. 2009 The calcium-dependent and calcium-independent membrane binding of synaptotagmin 1: two modes of C2B binding J Mol Biol 387 2 284 294 1:CAS:528:DC%2BD1MXjt1Smurs%3D 19302798
53. JA Peterson S Patton M Hamosh 1998 Glycoproteins of the human milk fat globule in the protection of the breast-fed infant against infections Biol Neonate 74 2 143 162 1:CAS:528:DyaK1cXkvFWjs7Y%3D 9691156
54. J Hvarregaard, et al. 1996 Characterization of glycoprotein PAS-6/7 from membranes of bovine milk fat globules Eur J Biochem 240 3 628 636 1:CAS:528:DyaK28XlvFKls7k%3D 8856064
55. MH Andersen, et al. 1997 Bovine PAS-6/7 binds alpha v beta 5 integrins and anionic phospholipids through two domains Biochemistry 36 18 5441 5446 1:CAS:528:DyaK2sXisFCjsbk%3D 9154926
56. MH Andersen, et al. 2000 Functional analyses of two cellular binding domains of bovine lactadherin Biochemistry 39 20 6200 6206 1:CAS:528: DC%2BD3cXis1Olsrg%3D 10821695
57. J Shi GE Gilbert 2003 Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites Blood 101 7 2628 2636 1:CAS:528:DC%2BD3sXivVWgu7o%3D 12517809
58. J Savill C Gregory 2007 Apoptotic PS to phagocyte TIM-4: eat me Immunity 27 6 830 832 1:CAS:528:DC%2BD1cXotFWm 18093535
59. N Kobayashi, et al. 2007 TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells Immunity 27 6 927 940 1:CAS:528:DC%2BD1cXotFan 18082433
60. M Miyanishi, et al. 2007 Identification of Tim4 as a phosphatidylserine receptor Nature 450 7168 435 439 1:CAS:528:DC%2BD2sXhtlajs77P 17960135
61. M Huang, et al. 2003 Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins Nat Struct Biol 10 9 751 756 1:CAS:528:DC%2BD3sXms1GktL8%3D 12923575
62. M Umeda, et al. 1989 Effective production of monoclonal antibodies against phosphatidylserine: stereo-specific recognition of phosphatidylserine by monoclonal antibody J Immunol 143 7 2273 2279 1:CAS:528:DyaL1MXlvFaktLg%3D 2476504
63. S Ran, et al. 2005 Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice Clin Cancer Res 11 4 1551 1562 1:CAS:528:DC%2BD2MXhvVSrtr0%3D 15746060
64. TA Luster, et al. 2006 Plasma protein beta-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells J Biol Chem 281 40 29863 29871 1:CAS:528:DC%2BD28XhtVahsbzK 16905548
65. JM Brown LD Attardi 2005 The role of apoptosis in cancer development and treatment response Nat Rev Cancer 5 3 231 237 1:CAS:528:DC%2BD2MXhslSnt74%3D 15738985
66. H Yaoita, et al. 2000 Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction Cardiovasc Res 45 3 630 641 1:CAS:528:DC%2BD3cXltVGksg%3D%3D 10728384
67. FD Kolodgie, et al. 1999 Apoptosis in human atherosclerotic plaques Apoptosis 4 1 5 10 1:CAS:528:DyaK1MXlsFShtbw%3D 14634290
68. J Narula, et al. 1999 Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy Proc Natl Acad Sci USA 96 14 8144 8149 1:CAS:528:DyaK1MXltVOrs7c%3D 10393962
69. MP Mattson 2000 Apoptosis in neurodegenerative disorders Nat Rev Mol Cell Biol 1 2 120 129 1:CAS:528:DC%2BD3MXivVGjtbk%3D 11253364
70. 2+-dependent phospholipid-binding protein Eur J Biochem 174 4 585 592 1:CAS:528:DyaL1MXhvFeltg%3D%3D 2455636
71. CM Lahorte, et al. 2004 Apoptosis-detecting radioligands: current state of the art and future perspectives Eur J Nucl Med Mol Imaging 31 6 887 919 1:CAS:528:DC%2BD2cXksVensb4%3D 15138718
72. A Faust, et al. 2009 Molecular imaging of apoptosis in vivo with scintigraphic and optical biomarkers-a status report Anticancer Agents Med Chem 9 9 968 985 1:CAS:528:DC%2BD1MXhtlKntbfO 19663786
73. EA Schellenberger R Weissleder L Josephson 2004 Optimal modification of annexin V with fluorescent dyes Chembiochem 5 3 271 274 1:CAS:528: DC%2BD2cXitlCrsbs%3D 14997518
74. JF Tait, et al. 2006 Improved detection of cell death in vivo with annexin v radiolabeled by site-specific methods J Nucl Med 47 9 1546 1553 1:CAS:528:DC%2BD28XhtVCmtLfK 16954565
75. JF Tait, et al. 2000 Development and characterization of annexin V mutants with endogenous chelation sites for (99m)Tc Bioconjug Chem 11 6 918 925 1:CAS:528:DC%2BD3cXnsVals7Y%3D 11087342
76. X Li, et al. 2008 Site-specific labeling of annexin V with F-18 for apoptosis imaging Bioconjug Chem 19 8 1684 1688 1:CAS:528:DC%2BD1cXosFKntbk%3D 18627198
77. M De Saint-Hubert, et al. 2010 Site-specific labeling of 'second generation' annexin V with 99mTc(CO)3 for improved imaging of apoptosis in vivo Bioorg Med Chem 18 3 1356 1363 20053567
78. L Prinzen, et al. 2007 Optical and magnetic resonance imaging of cell death and platelet activation using annexin A5-functionalized quantum dots Nano Lett 7 1 93 100 1:CAS:528:DC%2BD28XhtlSrsrnJ 17212446
79. E Schellenberger, et al. 2008 Linking proteins with anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis Small 4 2 225 230 1:CAS:528:DC%2BD1cXisFSks78%3D 18203233
80. GA van Tilborg, et al. 2006 Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis Bioconjug Chem 17 3 741 749 16704213
81. B Garnier, et al. 2009 Annexin A5-functionalized liposomes for targeting phosphatidylserine-exposing membranes Bioconjug Chem 20 11 2114 2122 1:CAS:528:DC%2BD1MXht1OitLrK 19835411
82. HI Jung, et al. 2004 Detection of apoptosis using the C2A domain of synaptotagmin I Bioconjug Chem 15 5 983 987 1:CAS:528:DC%2BD2cXmsVKiu7s%3D 15366950
83. M Zhao, et al. 2001 Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent Nat Med 7 11 1241 1244 1:CAS:528:DC%2BD3MXotlKks7w%3D 11689890
84. M Zhao, et al. 2006 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction J Nucl Med 47 8 1367 1374 1:CAS:528:DC%2BD28XptVajsrY%3D 16883018
85. J Shi, et al. 2006 Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell death Cytometry A 69 12 1193 1201 17123296
86. DE Sosnovik, et al. 2009 Molecular MRI detects low levels of cardiomyocyte apoptosis in a transgenic model of chronic heart failure Circ Cardiovasc Imaging 2 6 468 475 19920045
87. S Isobe, et al. 2006 Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5 J Nucl Med 47 9 1497 1505 1:CAS:528:DC%2BD28XhtVCmtLfM 16954559
88. N Haider, et al. 2009 Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis J Nucl Cardiol 16 5 753 762 19662466
89. D Hartung, et al. 2005 Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy J Nucl Med 46 12 2051 2056 1:CAS:528:DC%2BD28XivVSrtw%3D%3D 16330569
90. F Wang, et al. 2008 Imaging paclitaxel (chemotherapy)-induced tumor apoptosis with 99mTc C2A, a domain of synaptotagmin I: a preliminary study Nucl Med Biol 35 3 359 364 1:CAS:528:DC%2BD1cXjs1KitLg%3D 18355692
91. B Cornelissen, et al. 2005 In vivo apoptosis detection with radioiodinated Annexin V in LoVo tumour-bearing mice following Tipifarnib (Zarnestra, R115777) farnesyltransferase inhibitor therapy Nucl Med Biol 32 3 233 239 1:CAS:528:DC%2BD2MXjtV2isrs%3D 15820758
92. R Weissleder MJ Pittet 2008 Imaging in the era of molecular oncology Nature 452 7187 580 589 1:CAS:528:DC%2BD1cXktFCgt7Y%3D 18385732
93. H Kenis C Reutelingsperger 2009 Targeting phosphatidylserine in anti-cancer therapy Curr Pharm Des 15 23 2719 2723 1:CAS:528: DC%2BD1MXptVajs74%3D 19689342
94. H Kenis L Hofstra CP Reutelingsperger 2007 Annexin A5: shifting from a diagnostic towards a therapeutic realm Cell Mol Life Sci 64 22 2859 2862 1:CAS:528:DC%2BD2sXhsVals7jK 17876516
95. S Ran PE Thorpe 2002 Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy Int J Radiat Oncol Biol Phys 54 5 1479 1484 1:CAS:528:DC%2BD38XovFKjsLc%3D 12459374
96. H Kenis, et al. 2010 Annexin a5 uptake in ischemic myocardium: demonstration of reversible phosphatidylserine externalization and feasibility of radionuclide imaging J Nucl Med 51 2 259 267 1:CAS:528:DC%2BC3cXivFWmsb8%3D 20124049
97. JF Tait, et al. 1995 Prourokinase-annexin V chimeras. Construction, expression, and characterization of recombinant proteins J Biol Chem 270 37 21594 21599 1:CAS:528:DyaK2MXotFaju7w%3D 7665573
98. K Tanaka, et al. 1996 Preparation and characterization of a disulfide-linked bioconjugate of annexin V with the B-chain of urokinase: an improved fibrinolytic agent targeted to phospholipid-containing thrombi Biochemistry 35 3 922 929 1:CAS:528:DyaK28XhsFGksQ%3D%3D 8547274
99. X Huang, et al. 2006 A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties Blood 107 3 980 986 1:CAS:528:DC%2BD28Xht1Ontrw%3D 16195337
100. HO van Genderen, et al. 2008 Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization Biochim Biophys Acta 1783 6 953 963 18334229
101. FA Kuypers, et al. 2007 Interaction of an annexin V homodimer (Diannexin) with phosphatidylserine on cell surfaces and consequent antithrombotic activity Thromb Haemost 97 3 478 486 1:CAS:528:DC%2BD2sXkvVSgu7o%3D 17334517
102. X Huang M Bennett PE Thorpe 2005 A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice Cancer Res 65 10 4408 4416 1:CAS:528: DC%2BD2MXktlSmtLk%3D 15899833 (Pubitemid 40775680)
103. J He TA Luster PE Thorpe 2007 Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids Clin Cancer Res 13 17 5211 5218 1:CAS:528:DC%2BD2sXpvFGqs7k%3D 17785577
104. L Hofstra, et al. 2000 Visualisation of cell death in vivo in patients with acute myocardial infarction Lancet 356 9225 209 212 1:STN:280: DC%2BD3cvjtVemtA%3D%3D 10963199
105. BL Kietselaer, et al. 2007 Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure J Nucl Med 48 4 562 567 1:CAS:528:DC%2BD2sXhtVert7nJ 17401092
106. L Hofstra, et al. 2001 In vivo detection of apoptosis in an intracardiac tumor JAMA 285 14 1841 1842 1:STN:280:DC%2BD3M3jtVSjtg%3D%3D 11308396
107. BL Kietselaer J Narula L Hofstra 2007 The Annexin code: revealing endocarditis Eur Heart J 28 8 948 17085485
108. HA Andree, et al. 1990 Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers J Biol Chem 265 9 4923 4928 1:CAS:528:DyaK3cXhvFCjtbw%3D 2138622
109. JF Tait D Gibson K Fujikawa 1989 Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family J Biol Chem 264 14 7944 7949 1:CAS:528:DyaL1MXktF2ltrk%3D 2524476
110. J Shi, et al. 2004 Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature Biochim Biophys Acta 1667 1 82 90 1:CAS:528:DC%2BD2cXpsFWitb4%3D 15533308
111. Y Kuge, et al. 2004 Feasibility of 99mTc-annexin V for repetitive detection of apoptotic tumor response to chemotherapy: an experimental study using a rat tumor model J Nucl Med 45 2 309 312 1:CAS:528:DC%2BD2cXitVCrtbw%3D 14960654
112. AS Krishnan, et al. 2008 Detection of cell death in tumors by using MR imaging and a gadolinium-based targeted contrast agent Radiology 246 3 854 862 18187402
113. HC Manning, et al. 2008 Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer Clin Cancer Res 14 22 7413 7422 1:CAS:528:DC%2BD1cXhtlylur%2FF 19010858
114. C Shah, et al. 2009 Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer Clin Cancer Res 15 14 4712 4721 1:CAS:528:DC%2BD1MXosV2ltbw%3D 19584166
115. MS Kartachova, et al. 2008 99mTc-HYNIC-rh-annexin-V scintigraphy: visual and quantitative evaluation of early treatment-induced apoptosis to predict treatment outcome Nucl Med Commun 29 1 39 44 18049096
116. S Rottey, et al. 2007 (99m)Tc-HYNIC Annexin-V imaging of tumors and its relationship to response to radiotherapy and/or chemotherapy Q J Nucl Med Mol Imaging 51 2 182 188 1:STN:280:DC%2BD1c3lsVOrtA%3D%3D 17220821
117. H Kurihara, et al. 2008 Imaging and dosimetry of 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors Appl Radiat Isot 66 9 1175 1182 1:CAS:528:DC%2BD1cXptVSrtro%3D 18308577
118. RL Haas, et al. 2004 In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients Int J Radiat Oncol Biol Phys 59 3 782 787 15183481
119. D Loose, et al. 2007 Prognostic value of (99m)Tc-HYNIC Annexin-V imaging in squamous cell carcinoma of the head and neck Eur J Nucl Med Mol Imaging 35 1 47 52 17906858
120. J Narula, et al. 2001 Annexin-V imaging for noninvasive detection of cardiac allograft rejection Nat Med 7 12 1347 1352 1:CAS:528: DC%2BD3MXovFKmsbo%3D 11726976
121. W Martinet MM Kockx 2001 Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation Curr Opin Lipidol 12 5 535 541 1:CAS:528: DC%2BD3MXnslGjs7c%3D 11561173
122. L Rossig S Dimmeler AM Zeiher 2001 Apoptosis in the vascular wall and atherosclerosis Basic Res Cardiol 96 1 11 22 1:CAS:528:DC%2BD3MXhvFKgu7g%3D 11215528
123. NJ McCarthy MR Bennett 2000 The regulation of vascular smooth muscle cell apoptosis Cardiovasc Res 45 3 747 755 1:CAS:528:DC%2BD3cXltVGrsQ%3D%3D 10728397
124. KL Gabrielson, et al. 2008 Detection of dose response in chronic doxorubicin-mediated cell death with cardiac technetium 99m annexin V single-photon emission computed tomography Mol Imaging 7 3 132 138 1:CAS:528:DC%2BD1cXhsFWrt7vJ 19123983
125. X Zhu, et al. 2008 Early uptake of 99mTc-C2A in the acute phase of myocardial infarction as a prognostic indicator for follow-up cardiac dysfunction Nucl Med Commun 29 9 764 769 18677202
126. EA Dumont, et al. 2001 Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart Nat Med 7 12 1352 1355 1:CAS:528:DC%2BD3MXovFKmtrY%3D 11726977
127. W Fang, et al. 2007 SPECT imaging of myocardial infarction using 99mTc-labeled C2A domain of synaptotagmin I in a porcine ischemia-reperfusion model Nucl Med Biol 34 8 917 923 1:CAS:528:DC%2BD2sXht12jtrzE 17998093
128. LL Johnson, et al. 2005 99mTc-Annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries J Nucl Med 46 7 1186 1193 16000288
129. FD Kolodgie, et al. 2003 Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque Circulation 108 25 3134 3139 1:CAS:528:DC%2BD3sXpvVSjtL4%3D 14676140
130. BL Kietselaer, et al. 2004 Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis N Engl J Med 350 14 1472 1473 1:CAS:528:DC%2BD2cXivVamsL8%3D 15070807
131. M Lorberboym, et al. 2009 The use of 99mTc-recombinant human annexin V imaging for differential diagnosis of aseptic loosening and low-grade infection in hip and knee prostheses J Nucl Med 50 4 534 537 19289427
132. FG Blankenberg, et al. 2000 Radionuclide imaging of acute lung transplant rejection with annexin V Chest 117 3 834 840 1:STN:280:DC%2BD3c7nvFGluw%3D%3D 10713014
133. MH Kown, et al. 2001 In vivo imaging of acute cardiac rejection in human patients using (99m)technetium labeled annexin V Am J Transplant 1 3 270 277 1:STN:280:DC%2BD38zlvVansg%3D%3D 12102261
134. JM Van den Brande, et al. 2007 Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease Gut 56 4 509 517 17082252
135. FG Blankenberg, et al. 2006 99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibody Eur J Nucl Med Mol Imaging 33 5 566 574 1:CAS:528:DC%2BD28XktFSqsbw%3D 16477433
136. C Mari, et al. 2004 Detection of focal hypoxic-ischemic injury and neuronal stress in a rodent model of unilateral MCA occlusion/reperfusion using radiolabeled annexin V Eur J Nucl Med Mol Imaging 31 5 733 739 1:CAS:528:DC%2BD2cXjt1aiur8%3D 14985868
137. Y Lampl, et al. 2006 Annexin V SPECT imaging of phosphatidylserine expression in patients with dementia Neurology 66 8 1253 1254 1:CAS:528:DC%2BD28XjtFOrtLw%3D 16636246
138. M Lorberboym, et al. 2006 In vivo imaging of apoptosis in patients with acute stroke: correlation with blood-brain barrier permeability Brain Res 1103 1 13 19 1:CAS:528:DC%2BD28XntlWhs7k%3D 16806116
139. S Schmitz-Valckenberg, et al. 2008 Real-time in vivo imaging of retinal cell apoptosis after laser exposure Invest Ophthalmol Vis Sci 49 6 2773 2780 18281610
140. M Cordeiro, et al. 2010 Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo Cell Death Dis 1 e3 10.1038/cddis.2009.3
141. AM Post, et al. 2002 Imaging cell death with radiolabeled annexin V in an experimental model of rheumatoid arthritis J Nucl Med 43 10 1359 1365 1:CAS:528:DC%2BD38XotlKjs7s%3D 12368374
142. Z Medarova, et al. 2005 Imaging beta-cell death with a near-infrared probe Diabetes 54 6 1780 1788 1:CAS:528:DC%2BD2MXltVait7g%3D 15919800